Hormonal Carcinogenesis: Proceedings of the First International Symposium
In the past decade there has been a growing public interest and resurgence in research in the field of hormonal carcinogenesis. This is due to the widespread use of therapeutic hormonal agents worldwide and to the increasing awareness of the causal association of hormones, both endogenous and exogen...
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York, NY
Springer New York
1992
|
| Schlagworte: | |
| Online-Zugang: | UBR01 URL des Erstveröffentlichers |
| Zusammenfassung: | In the past decade there has been a growing public interest and resurgence in research in the field of hormonal carcinogenesis. This is due to the widespread use of therapeutic hormonal agents worldwide and to the increasing awareness of the causal association of hormones, both endogenous and exogenously administered, and a variety of human cancers. These associations include estrogens in uterine, cervical, vaginal, liver, testicular, prostatic, and possible breast cancers; progesterone and progestational hormones in breast cancer; androgens and anabolic steroids in hepatic and prostatic cancers. Additionally, gonadotrophins playa role in the etiology of ovarian and testicular cancers and thyroid-stimulating hormones in thyroid cancers. Therefore, hormonal carcinogenesis encompasses the study of both natural and synthetic hormonal agents, including growth factors and other peptide and protein factors, which contribute substantially to the etiology of both human and animal neoplasms, benign or malignant. Hormones may be involved in all aspects of neoplastic transformation, including initiation, promotion, and progression, and the inhibition of these processes. There are a number of important issues in women's health that need to be addressed. More than 40 million U. S. women are menopausal, and these women have a life expectancy of over 30 years after the menopause. When these figures are multiplied worldwide, the numbers become staggering. After the menopause, estrogen replacement therapy (ERT) is the choice of most women in industrialized countries |
| Beschreibung: | 1 Online-Ressource (XXXIV, 340 p) |
| ISBN: | 9781461392088 |
| DOI: | 10.1007/978-1-4613-9208-8 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046143755 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1992 |||| o||u| ||||||eng d | ||
| 020 | |a 9781461392088 |9 978-1-4613-9208-8 | ||
| 024 | 7 | |a 10.1007/978-1-4613-9208-8 |2 doi | |
| 035 | |a (ZDB-2-SME)978-1-4613-9208-8 | ||
| 035 | |a (OCoLC)1119002837 | ||
| 035 | |a (DE-599)BVBBV046143755 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.994 |2 23 | |
| 084 | |a XH 5305 |0 (DE-625)152911:12911 |2 rvk | ||
| 245 | 1 | 0 | |a Hormonal Carcinogenesis |b Proceedings of the First International Symposium |c edited by Jonathan J. Li, Satyabrata Nandi, Sara Antonia Li |
| 264 | 1 | |a New York, NY |b Springer New York |c 1992 | |
| 300 | |a 1 Online-Ressource (XXXIV, 340 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 520 | |a In the past decade there has been a growing public interest and resurgence in research in the field of hormonal carcinogenesis. This is due to the widespread use of therapeutic hormonal agents worldwide and to the increasing awareness of the causal association of hormones, both endogenous and exogenously administered, and a variety of human cancers. These associations include estrogens in uterine, cervical, vaginal, liver, testicular, prostatic, and possible breast cancers; progesterone and progestational hormones in breast cancer; androgens and anabolic steroids in hepatic and prostatic cancers. Additionally, gonadotrophins playa role in the etiology of ovarian and testicular cancers and thyroid-stimulating hormones in thyroid cancers. Therefore, hormonal carcinogenesis encompasses the study of both natural and synthetic hormonal agents, including growth factors and other peptide and protein factors, which contribute substantially to the etiology of both human and animal neoplasms, benign or malignant. Hormones may be involved in all aspects of neoplastic transformation, including initiation, promotion, and progression, and the inhibition of these processes. There are a number of important issues in women's health that need to be addressed. More than 40 million U. S. women are menopausal, and these women have a life expectancy of over 30 years after the menopause. When these figures are multiplied worldwide, the numbers become staggering. After the menopause, estrogen replacement therapy (ERT) is the choice of most women in industrialized countries | ||
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Oncology | |
| 650 | 0 | 7 | |a Hormon |0 (DE-588)4025864-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Carcinogenese |0 (DE-588)4069853-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Sexualhormon |0 (DE-588)4054683-4 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1991 |z Cancun |2 gnd-content | |
| 689 | 0 | 0 | |a Carcinogenese |0 (DE-588)4069853-1 |D s |
| 689 | 0 | 1 | |a Hormon |0 (DE-588)4025864-6 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Carcinogenese |0 (DE-588)4069853-1 |D s |
| 689 | 1 | 1 | |a Sexualhormon |0 (DE-588)4054683-4 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Li, Jonathan J. |4 edt | |
| 700 | 1 | |a Nandi, Satyabrata |4 edt | |
| 700 | 1 | |a Li, Sara Antonia |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461392101 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780387977973 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461392095 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4613-9208-8 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031523939 | ||
| 966 | e | |u https://doi.org/10.1007/978-1-4613-9208-8 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180478261985280 |
|---|---|
| any_adam_object | |
| author2 | Li, Jonathan J. Nandi, Satyabrata Li, Sara Antonia |
| author2_role | edt edt edt |
| author2_variant | j j l jj jjl s n sn s a l sa sal |
| author_facet | Li, Jonathan J. Nandi, Satyabrata Li, Sara Antonia |
| building | Verbundindex |
| bvnumber | BV046143755 |
| classification_rvk | XH 5305 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-1-4613-9208-8 (OCoLC)1119002837 (DE-599)BVBBV046143755 |
| dewey-full | 616.994 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.994 |
| dewey-search | 616.994 |
| dewey-sort | 3616.994 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-1-4613-9208-8 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03696nmm a2200565zc 4500</leader><controlfield tag="001">BV046143755</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1992 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781461392088</subfield><subfield code="9">978-1-4613-9208-8</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4613-9208-8</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-1-4613-9208-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119002837</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046143755</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.994</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 5305</subfield><subfield code="0">(DE-625)152911:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Hormonal Carcinogenesis</subfield><subfield code="b">Proceedings of the First International Symposium</subfield><subfield code="c">edited by Jonathan J. Li, Satyabrata Nandi, Sara Antonia Li</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">Springer New York</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XXXIV, 340 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In the past decade there has been a growing public interest and resurgence in research in the field of hormonal carcinogenesis. This is due to the widespread use of therapeutic hormonal agents worldwide and to the increasing awareness of the causal association of hormones, both endogenous and exogenously administered, and a variety of human cancers. These associations include estrogens in uterine, cervical, vaginal, liver, testicular, prostatic, and possible breast cancers; progesterone and progestational hormones in breast cancer; androgens and anabolic steroids in hepatic and prostatic cancers. Additionally, gonadotrophins playa role in the etiology of ovarian and testicular cancers and thyroid-stimulating hormones in thyroid cancers. Therefore, hormonal carcinogenesis encompasses the study of both natural and synthetic hormonal agents, including growth factors and other peptide and protein factors, which contribute substantially to the etiology of both human and animal neoplasms, benign or malignant. Hormones may be involved in all aspects of neoplastic transformation, including initiation, promotion, and progression, and the inhibition of these processes. There are a number of important issues in women's health that need to be addressed. More than 40 million U. S. women are menopausal, and these women have a life expectancy of over 30 years after the menopause. When these figures are multiplied worldwide, the numbers become staggering. After the menopause, estrogen replacement therapy (ERT) is the choice of most women in industrialized countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology </subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hormon</subfield><subfield code="0">(DE-588)4025864-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Carcinogenese</subfield><subfield code="0">(DE-588)4069853-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Sexualhormon</subfield><subfield code="0">(DE-588)4054683-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1991</subfield><subfield code="z">Cancun</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Carcinogenese</subfield><subfield code="0">(DE-588)4069853-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Hormon</subfield><subfield code="0">(DE-588)4025864-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Carcinogenese</subfield><subfield code="0">(DE-588)4069853-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Sexualhormon</subfield><subfield code="0">(DE-588)4054683-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Jonathan J.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nandi, Satyabrata</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Sara Antonia</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461392101</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780387977973</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461392095</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4613-9208-8</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031523939</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4613-9208-8</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1991 Cancun gnd-content |
| genre_facet | Konferenzschrift 1991 Cancun |
| id | DE-604.BV046143755 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:24Z |
| institution | BVB |
| isbn | 9781461392088 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031523939 |
| oclc_num | 1119002837 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XXXIV, 340 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1992 |
| publishDateSearch | 1992 |
| publishDateSort | 1992 |
| publisher | Springer New York |
| record_format | marc |
| spelling | Hormonal Carcinogenesis Proceedings of the First International Symposium edited by Jonathan J. Li, Satyabrata Nandi, Sara Antonia Li New York, NY Springer New York 1992 1 Online-Ressource (XXXIV, 340 p) txt rdacontent c rdamedia cr rdacarrier In the past decade there has been a growing public interest and resurgence in research in the field of hormonal carcinogenesis. This is due to the widespread use of therapeutic hormonal agents worldwide and to the increasing awareness of the causal association of hormones, both endogenous and exogenously administered, and a variety of human cancers. These associations include estrogens in uterine, cervical, vaginal, liver, testicular, prostatic, and possible breast cancers; progesterone and progestational hormones in breast cancer; androgens and anabolic steroids in hepatic and prostatic cancers. Additionally, gonadotrophins playa role in the etiology of ovarian and testicular cancers and thyroid-stimulating hormones in thyroid cancers. Therefore, hormonal carcinogenesis encompasses the study of both natural and synthetic hormonal agents, including growth factors and other peptide and protein factors, which contribute substantially to the etiology of both human and animal neoplasms, benign or malignant. Hormones may be involved in all aspects of neoplastic transformation, including initiation, promotion, and progression, and the inhibition of these processes. There are a number of important issues in women's health that need to be addressed. More than 40 million U. S. women are menopausal, and these women have a life expectancy of over 30 years after the menopause. When these figures are multiplied worldwide, the numbers become staggering. After the menopause, estrogen replacement therapy (ERT) is the choice of most women in industrialized countries Oncology Oncology Hormon (DE-588)4025864-6 gnd rswk-swf Carcinogenese (DE-588)4069853-1 gnd rswk-swf Sexualhormon (DE-588)4054683-4 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1991 Cancun gnd-content Carcinogenese (DE-588)4069853-1 s Hormon (DE-588)4025864-6 s DE-604 Sexualhormon (DE-588)4054683-4 s Li, Jonathan J. edt Nandi, Satyabrata edt Li, Sara Antonia edt Erscheint auch als Druck-Ausgabe 9781461392101 Erscheint auch als Druck-Ausgabe 9780387977973 Erscheint auch als Druck-Ausgabe 9781461392095 https://doi.org/10.1007/978-1-4613-9208-8 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Hormonal Carcinogenesis Proceedings of the First International Symposium Oncology Oncology Hormon (DE-588)4025864-6 gnd Carcinogenese (DE-588)4069853-1 gnd Sexualhormon (DE-588)4054683-4 gnd |
| subject_GND | (DE-588)4025864-6 (DE-588)4069853-1 (DE-588)4054683-4 (DE-588)1071861417 |
| title | Hormonal Carcinogenesis Proceedings of the First International Symposium |
| title_auth | Hormonal Carcinogenesis Proceedings of the First International Symposium |
| title_exact_search | Hormonal Carcinogenesis Proceedings of the First International Symposium |
| title_full | Hormonal Carcinogenesis Proceedings of the First International Symposium edited by Jonathan J. Li, Satyabrata Nandi, Sara Antonia Li |
| title_fullStr | Hormonal Carcinogenesis Proceedings of the First International Symposium edited by Jonathan J. Li, Satyabrata Nandi, Sara Antonia Li |
| title_full_unstemmed | Hormonal Carcinogenesis Proceedings of the First International Symposium edited by Jonathan J. Li, Satyabrata Nandi, Sara Antonia Li |
| title_short | Hormonal Carcinogenesis |
| title_sort | hormonal carcinogenesis proceedings of the first international symposium |
| title_sub | Proceedings of the First International Symposium |
| topic | Oncology Oncology Hormon (DE-588)4025864-6 gnd Carcinogenese (DE-588)4069853-1 gnd Sexualhormon (DE-588)4054683-4 gnd |
| topic_facet | Oncology Oncology Hormon Carcinogenese Sexualhormon Konferenzschrift 1991 Cancun |
| url | https://doi.org/10.1007/978-1-4613-9208-8 |
| work_keys_str_mv | AT lijonathanj hormonalcarcinogenesisproceedingsofthefirstinternationalsymposium AT nandisatyabrata hormonalcarcinogenesisproceedingsofthefirstinternationalsymposium AT lisaraantonia hormonalcarcinogenesisproceedingsofthefirstinternationalsymposium |